However, triple-negative breast cancers (TNBC) are a heterogeneous subtype of BCs that lack nuclear expression of estrogen receptor-α (ERα-66kD) and progesterone receptor (PR) and have no overexpression of HER2 receptors [4,5]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.